Mega Genomics Stock

Mega Genomics EBIT

The EBIT of Mega Genomics (6667.HK) as of Aug 1, 2026 is 45.22 M CNY. In the previous year, EBIT was 63.97 M CNY — a change of -29.32% (lower).

EBIT

45.22 MCNY

YoY

-29.32%

Last updated:

In 2026, Mega Genomics's EBIT was 45.22 M CNY, a -29.32% increase from the 63.97 M CNY EBIT recorded in the previous year.

The Mega Genomics EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M CNY)
Date
EBIT (M CNY)
Jan 1, 2019
64.33 base
Jan 1, 2020
111.45 base
Jan 1, 2021
109.80 base
Jan 1, 2022
2.53 base
Jan 1, 2023
18.93 base
Jan 1, 2024
63.97 base
Jan 1, 2025
45.22 base
YEAREBIT (M CNY)
2025 45.22
2024 63.97
2023 18.93
2022 2.53
2021 109.80
2020 111.45
2019 64.33
Access this data via the Eulerpool API

Mega Genomics Revenue

Mega Genomics Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
123.70 M CNY
64.33 M CNY
29.69 M CNY
Jan 1, 2020
203.22 M CNY
111.45 M CNY
79.10 M CNY
Jan 1, 2021
237.19 M CNY
109.80 M CNY
79.02 M CNY
Jan 1, 2022
145.73 M CNY
2.53 M CNY
-17.62 M CNY
Jan 1, 2023
151.30 M CNY
18.93 M CNY
30.04 M CNY
Jan 1, 2024
189.79 M CNY
63.97 M CNY
52.06 M CNY
Jan 1, 2025
285.62 M CNY
45.22 M CNY
30.42 M CNY

Mega Genomics Margins

Mega Genomics stock margins

The Mega Genomics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Mega Genomics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Mega Genomics.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
63.44 %
52.00 %
24.00 %
Jan 1, 2020
71.96 %
54.84 %
38.92 %
Jan 1, 2021
70.27 %
46.29 %
33.31 %
Jan 1, 2022
56.08 %
1.73 %
-12.09 %
Jan 1, 2023
58.36 %
12.51 %
19.85 %
Jan 1, 2024
72.67 %
33.70 %
27.43 %
Jan 1, 2025
47.49 %
15.83 %
10.65 %

Mega Genomics Stock analysis

What does Mega Genomics do? Mega Genomics is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Mega Genomics's EBIT

Mega Genomics's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Mega Genomics's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Mega Genomics's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Mega Genomics’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Mega Genomics stock

EBIT of Mega Genomics is 45.22 M CNY in 2026.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Mega Genomics

All Key Metrics — Mega Genomics